Joel R. Eisner

Dr. Eisner serves as Senior Vice President of Clinical & Corporate Development at GeneCentric. Previously he was a co-founder of Innocrin Therapeutics and served as Vice President of Clinical Operations and Vice President of Medical and Scientific Affairs. Prior to Innocrin, he served as Director of Product Development at Viamet Pharmaceuticals. He also was a Principal at Cato BioVentures where he held senior management positions in several portfolio companies. He also served as a Clinical Research Scientist at Insmed, Inc. Dr. Eisner received his PhD from the University of Wisconsin – Madison in Endocrinology and Physiology and conducted clinical research at Northwestern University Medical School and Brigham and Women’s Hospital.